Climb Bio, Inc. (CLYM)

Climb Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	35.69	87.23	93.11	43.59	46.92
Short-Term Investments	65.4	63.69	13.69	79.98	89.56
Cash & Short-Term Investments	101.08	150.92	106.8	123.57	136.48
Cash Growth	-33.02%	41.31%	-13.57%	-9.46%	566.18%
Other Current Assets	4.77	3.95	3.46	10.83	11.77
Total Current Assets	105.85	154.87	110.26	134.39	148.25
Net Property, Plant & Equipment	0.79	0.69	0.2	0.47	-
Long-Term Investments	59.57	61.61	-	-	24.92
Other Long-Term Assets	1.53	0.02	0.02	0.13	0.07
Total Assets	167.74	217.19	110.47	134.99	173.24
Accounts Payable	2.27	0.71	0.07	0.75	1.4
Accrued Expenses	4.46	4.07	2.43	5.05	4.63
Current Portion of Leases	0.26	0.16	0.33	0.3	-
Total Current Liabilities	6.98	4.93	2.83	6.1	6.03
Long-Term Leases	0.29	0.38	0.02	0.18	-
Other Long-Term Liabilities	-	-	0.02	-	0.01
Total Long-Term Liabilities	0.29	0.38	0.04	0.18	0.01
Total Liabilities	7.27	5.31	2.87	6.28	6.04
Common Stock	0.01	0.01	0	0	0
Additional Paid-in Capital	449.76	441.73	263.58	249.93	242.94
Accumulated Other Comprehensive Income	0.44	0.02	-0	-0.36	-0.12
Retained Earnings	-289.73	-229.88	-155.98	-120.86	-75.62
Total Common Shareholders' Equity	160.48	211.88	107.6	128.72	167.2
Shareholders' Equity	160.48	211.88	107.6	128.72	167.2
Total Liabilities & Equity	167.74	217.19	110.47	134.99	173.24
Total Debt	0.54	0.53	0.35	0.48	0
Net Cash (Debt)	100.54	150.39	106.45	123.09	136.48
Net Cash Growth	-33.15%	41.28%	-13.52%	-9.81%	566.18%
Net Cash Per Share	1.48	3.12	-	4.68	11.13
Book Value	160.48	211.88	107.6	128.72	167.2
Book Value Per Share	2.37	4.40	-	4.89	13.64
Tangible Book Value	160.48	211.88	107.6	128.72	167.2
Tangible Book Value Per Share	2.37	4.40	-	4.89	13.64

Updated Mar 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q